RxDoctor Payments Data

Catherine Almeter, PA

Physician Assistant · Buffalo, NYNPI 1003480195

Payments from drug & device makers

$429in general payments, 2019–2025

Across 21 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$87
  • GSK$85
  • AstraZeneca$64
  • Novo Nordisk$60
  • Lilly USA, LLC$47
  • Bayer$35
  • plus $51 from 2 others

What the payments were for

  • Food & beverage$429100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$429 in reported general payments places this provider in the 60th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$28,032
Medicare patients
155
Services billed
327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$104,508
EliquisApixaban67$83,407
JardianceEmpagliflozin58$58,634
XareltoRivaroxaban28$32,992
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$32,463
TrulicityDulaglutide22$26,346
RybelsusSemaglutide23$24,159
Spiriva RespimatTiotropium Bromide19$14,568
TradjentaLinagliptin11$10,462
Synjardy XrEmpagliflozin/Metformin Hcl11$6,831
FarxigaDapagliflozin Propanediol11$5,879
Atorvastatin Calcium340$5,262
Combivent RespimatIpratropium/Albuterol Sulfate11$4,709
Levothyroxine Sodium235$4,668
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate23$4,555

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$60$128,667105 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Synjardy Xr, Combivent Respimat$87$95,205110 claims
GSKTrelegy Ellipta$85$32,46352 claims
Lilly USA, LLCTrulicity$47$26,34622 claims
AstraZenecaFarxiga$64$5,87911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →